ShenZhen Consys Science & Technology Co., Ltd. (688788.SS)
CNY 33.8
(-1.26%)
CNY 33.8
(-1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -129.08 Million | -12.84 Million | -90.49 Million | 55.29 Million | -245.7 Million | -59.6 Million |
| Net Income | -221.53 Million | -195.95 Million | 176.37 Million | 175.7 Million | 216.46 Million | 205.16 Million |
| Depreciation & Amortization | 62.69 Million | 29.22 Million | 21.31 Million | 9.6 Million | 5.52 Million | 3.37 Million |
| Deferred income taxes | -5.05 Million | -16.05 Million | -3.31 Million | -2 Million | -7.31 Million | -136.2 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -14.84 Million | 39.96 Million | -311.24 Million | -148.17 Million | -524.29 Million | -306.94 Million |
| Other non-cash items | 1.24 Million | 113.91 Million | 23.06 Million | 18.16 Million | 56.6 Million | 38.8 Million |
| Investing Cash Flow | -18.29 Million | -72.61 Million | -19.64 Million | -22.4 Million | -16.46 Million | -5.37 Million |
| Investments in PPE | -23.3 Million | -52.78 Million | -11.43 Million | -22.4 Million | -14.81 Million | -5.37 Million |
| Acquisitions | -5 Million | -19.83 Million | - | 1000.00 | 1950.00 | - |
| Investment purchases | - | - | -8.2 Million | - | -1.65 Million | - |
| Sales/Maturities of investments | - | - | - | - | -1950.00 | - |
| Other Investing Activities | 10 Million | 3099.95 | - | -22.4 Million | 1950.00 | -5.37 Million |
| Financing Cash Flow | -38.57 Million | -79.54 Million | -70.62 Million | 1.81 Billion | 219.79 Million | 86.01 Million |
| Debt repayment | -7.54 Million | -1.69 Million | -10.19 Million | -236.25 Million | -84.09 Million | -7.21 Million |
| Dividends payments | - | -75.53 Million | -60.42 Million | -7.39 Million | -7.85 Million | -1.35 Million |
| Common Stock Repurchased | -34.92 Million | - | - | -1.92 Billion | - | - |
| Common Stock Issuance | - | - | - | 1.92 Billion | - | - |
| Other Financing Activities | -46.11 Million | -2.31 Million | -0.82 | 2.05 Billion | 311.74 Million | 94.57 Million |
| Accounts receivables | -7.7 Million | 119.57 Million | -146.6 Million | -6.78 Million | -479.23 Million | -399.46 Million |
| Accounts payables | -1.77 Million | -26.55 Million | -191.3 Million | -29.66 Million | 77.58 Million | 143.01 Million |
| Inventory | -310.71 Thousand | -37 Million | 29.98 Million | -109.73 Million | -115.33 Million | -50.36 Million |
| Other working capital | -6.83 Million | -16.05 Million | -3.31 Million | -2 Million | -7.31 Million | -256.58 Million |
| Cash at beginning of period | 1.52 Billion | 1.69 Billion | 1.87 Billion | 24.54 Million | 66.92 Million | 45.88 Million |
| Cash at end of period | 1.33 Billion | 1.52 Billion | 1.69 Billion | 1.87 Billion | 24.54 Million | 66.92 Million |
| Capital Expenditure | -23.3 Million | -52.78 Million | -11.43 Million | -22.4 Million | -14.81 Million | -5.37 Million |
| Effect of forex changes on cash | - | -0.45 | 0.17 | 1.15 | 0.58 | -0.27 |
| Net cash flow / Change in cash | -185.95 Million | -165 Million | -180.75 Million | 1.84 Billion | -42.37 Million | 21.03 Million |
| Free Cash Flow | -152.38 Million | -65.62 Million | -101.92 Million | 32.89 Million | -260.51 Million | -64.97 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -51.91 Million | -86.26 Million | -53.53 Million | -24.11 Million | -221.53 Million | -59.92 Million |
| Depreciation & Amortization | - | 11.25 Million | 11.25 Million | 62.69 Million | 62.69 Million | -17.1 Million |
| Deferred income taxes | - | - | - | - | -5.05 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -8.01 Million | -14.84 Million | 23.78 Million |
| Other non-cash items | -35.48 Million | 97.4 Million | 27.49 Million | -16.09 Million | 1.24 Million | -35.27 Million |
| Investing Cash Flow | 241.01 Million | -753.67 Million | -5.03 Million | 1.7 Million | -18.29 Million | -1.48 Million |
| Investments in PPE | -981.93 Thousand | -1.67 Million | -5.03 Million | -8.5 Million | -23.3 Million | -1.49 Million |
| Acquisitions | 914.72 Thousand | - | 794.68 | -5 Million | -5 Million | 2000.00 |
| Investment purchases | 752 Million | -752 Million | - | 5.21 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 242 Million | -752 Million | 794.00 | 15.21 Million | 10 Million | 2000.00 |
| Financing Cash Flow | -7.04 Million | -7.9 Million | 2.35 Million | -8.95 Million | -38.57 Million | -35.21 Million |
| Debt repayment | -7.37 Million | -1.81 Million | -6.71 Million | -4.66 Million | -7.54 Million | -2.81 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 2.13 Million | -2.13 Million | - | -4.89 Million | -34.92 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 334.5 Thousand | 4.35 Million | -4.35 Million | -13.62 Million | -46.11 Million | -32.4 Million |
| Accounts receivables | - | - | - | -7.7 Million | -7.7 Million | 21.18 Million |
| Accounts payables | - | - | - | - | -1.77 Million | 5.14 Million |
| Inventory | - | - | - | -310.71 Thousand | -310.71 Thousand | 2.6 Million |
| Other working capital | - | - | - | - | - | -5.14 Million |
| Cash at beginning of period | 548.99 Million | 1.31 Billion | 1.33 Billion | 1.33 Billion | 1.52 Billion | 1.45 Billion |
| Cash at end of period | 695.57 Million | 551.6 Million | 1.31 Billion | 1.33 Billion | 1.33 Billion | 1.33 Billion |
| Capital Expenditure | -981.93 Thousand | -1.67 Million | -5.03 Million | -8.5 Million | -23.3 Million | -1.49 Million |
| Effect of forex changes on cash | - | - | - | - | - | -0.26 |
| Net cash flow / Change in cash | 146.57 Million | -759.14 Million | -28.71 Million | 7.21 Million | -185.95 Million | -125.21 Million |
| Free Cash Flow | -88.37 Million | -1.78 Million | -31.06 Million | 5.95 Million | -152.38 Million | -90 Million |
MEDICAMEQ
3880
BHC
YIPS
STMEF
ALVAZ